{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:22:43Z","timestamp":1785900163920,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Key Project for Drug Innovation","award":["2009ZX09102-123"],"award-info":[{"award-number":["2009ZX09102-123"]}]},{"name":"Key Project for Drug Innovation","award":["2009ZX09302-003"],"award-info":[{"award-number":["2009ZX09302-003"]}]},{"name":"Ministry of Science and Technology of China"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81102492"],"award-info":[{"award-number":["81102492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ejphar.2012.04.028","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T22:17:05Z","timestamp":1335046625000},"page":"156-164","source":"Crossref","is-referenced-by-count":37,"title":["Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes"],"prefix":"10.1016","volume":"685","author":[{"given":"Guifen","family":"Qiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bainian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.04.028_bb0005","first-page":"MS6","article-title":"Safety and efficacy of combined ezetimibe\/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease","volume":"15","author":"Abel","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/HYPERTENSIONAHA.106.085654","article-title":"Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population","volume":"50","author":"Aksnes","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0168-8278(92)90168-O","article-title":"Increased transforming growth factor-beta 1 gene expression in human liver disease","volume":"14","author":"Annoni","year":"1992","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/VHRM.S1991","article-title":"Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers","volume":"4","author":"Ban","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0025","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0035","first-page":"65","article-title":"The respiratory chain and oxidative phosphorylation","volume":"17","author":"Chance","year":"1956","journal-title":"Adv. Enzymol. Relat. Subj. Biochem."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0040","first-page":"71","article-title":"Diagnostic criteria of nonalcoholic fatty liver disease","volume":"11","author":"Chinese Society of Hepatology","year":"2003","journal-title":"Chin. J. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0050","doi-asserted-by":"crossref","first-page":"II100","DOI":"10.1161\/01.HYP.18.4_Suppl.II100","article-title":"Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia","volume":"18","author":"Dzau","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2001-12926","article-title":"Clinical features and natural history of nonalcoholic steatosis syndromes","volume":"21","author":"Falck-Ytter","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0060","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0016-5085(99)70413-0","article-title":"The virtuosity of hepatic stellate cells","volume":"117","author":"Friedman","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0065","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/ndt\/gfn230","article-title":"Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy","volume":"23","author":"Galle","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2009.04.042","article-title":"Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?","volume":"614","author":"Halici","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0080","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/hy1101.092970","article-title":"Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats","volume":"38","author":"Henriksen","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0085","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2005.02.001","article-title":"Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance","volume":"128","author":"Ibdah","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0090","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1111\/j.1440-1746.2006.04658.x","article-title":"Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis","volume":"22","author":"Kisseleva","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0095","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0100","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1096\/fasebj.11.11.9285483","article-title":"The lipid peroxidation end product 4-hydroxy-2, 3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis","volume":"11","author":"Leonarduzzi","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0167-0115(03)00192-7","article-title":"Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response","volume":"116","author":"Leung","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0110","first-page":"217","article-title":"Detection of collagens in hypertrophic scars by picrosirius polarization method","volume":"22","author":"Li","year":"2002","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0115","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M807616200","article-title":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3748\/wjg.v4.i6.497","article-title":"Effect of lipid on proliferation and activation of rat hepatic stellate cells (I)","volume":"4","author":"Lu","year":"1998","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0130","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/hep.21062","article-title":"Apoptosis and necrosis in the liver: a tale of two deaths?","volume":"43","author":"Malhi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/BJ20080868","article-title":"High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo","volume":"417","author":"Mantena","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0140","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1042\/CBI20090074","article-title":"Angiotensin II increases mRNA levels of all TGF-beta isoforms in quiescent and activated rat hepatic stellate cells","volume":"34","author":"Moreno-Alvarez","year":"2010","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2004.02025.x","article-title":"Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial","volume":"20","author":"Nair","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0155","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1172\/JCI114643","article-title":"Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis","volume":"85","author":"Nakatsukasa","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0676.1991.tb00499.x","article-title":"Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis","volume":"11","author":"Nouchi","year":"1991","journal-title":"Liver"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0165","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1073\/pnas.89.12.5408","article-title":"Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1","volume":"89","author":"Oberhammer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(01)00146-5","article-title":"Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis","volume":"35","author":"Paizis","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0175","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","article-title":"NASH: a mitochondrial disease","volume":"42","author":"Pessayre","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0180","series-title":"Mitochondria","first-page":"4","author":"Pon","year":"2007"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0185","first-page":"801","article-title":"Effect of metformin on the formation of hepatic fibrosis in type 2 diabetic rats","volume":"45","author":"Qiang","year":"2010","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0028-1091986","article-title":"Effects of weight loss on nonalcoholic fatty liver disease","volume":"28","author":"Rafiq","year":"2008","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0195","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0200","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2174\/092986710791698530","article-title":"Targeting mitochondria: a new promising approach for the treatment of liver diseases","volume":"17","author":"Serviddio","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2012.04.028_bb0205","first-page":"275","article-title":"Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations","volume":"24","author":"Silverman","year":"1989","journal-title":"Pathol. Annu."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0210","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/diabetes.48.10.2066","article-title":"Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation","volume":"48","author":"Singh","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0215","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1478-3231.2005.01130.x","article-title":"High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase","volume":"25","author":"Sugimoto","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0220","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0225","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0230","first-page":"643","article-title":"Nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems","volume":"22","author":"Tiniakos","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0235","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0929-6646(09)60202-3","article-title":"Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic fatty liver disease","volume":"105","author":"Wang","year":"2006","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3748\/wjg.14.193","article-title":"Nonalcoholic fatty liver disease and mitochondrial dysfunction","volume":"14","author":"Wei","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0250","doi-asserted-by":"crossref","first-page":"E841","DOI":"10.1152\/ajpendo.00653.2006","article-title":"Insulin regulation of MCP-1 in human adipose tissue of obese and lean women","volume":"294","author":"Westerbacka","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db06-1163","article-title":"Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0255","first-page":"621","article-title":"Relationship between the activation of hepatic stellate cell and the early stage of liver fibrosis in experimental diabetic tree shrews","volume":"26","author":"Xian","year":"2006","journal-title":"Ji Chu Yi Xue Yu Lin Chuang"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0260","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1440-1746.2006.04331.x","article-title":"Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats","volume":"21","author":"Xu","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0265","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2012.04.028_bb0270","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00004872-200211000-00001","article-title":"Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?","volume":"20","author":"Zanchetti","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2012.04.028_bb0275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1523-1755.1998.00815.x","article-title":"Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system","volume":"53","author":"Ziyadeh","year":"1998","journal-title":"Kidney Int."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912003627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912003627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T17:50:40Z","timestamp":1561657840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912003627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":55,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0014299912003627"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.04.028","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}